ZA913073B - Veterinary treatment - Google Patents

Veterinary treatment

Info

Publication number: ZA913073B
Authority: ZA; South Africa
Prior art keywords: veterinary treatment; veterinarily acceptable; treatment; acceptable derivative; amoxycillin
Prior art date: 1990-04-26

Application number

ZA913073A

Other languages

English (en)

Inventor

Victor Charles Cracknell

Charles Cracknell Victor

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-26

Filing date

1991-04-24

Publication date

1992-03-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10675074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA913073(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-04-24 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1992-03-25 Publication of ZA913073B publication Critical patent/ZA913073B/xx

Links

201000001178 Bacterial Pneumonia Diseases 0.000 abstract 1
HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 abstract 1
206010037660 Pyrexia Diseases 0.000 abstract 1
241000282887 Suidae Species 0.000 abstract 1
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 abstract 1
229960003022 amoxicillin Drugs 0.000 abstract 1
HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 abstract 1
229960003324 clavulanic acid Drugs 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fodder In General (AREA)
Saccharide Compounds (AREA)

ZA913073A 1990-04-26 1991-04-24 Veterinary treatment ZA913073B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB909009446A GB9009446D0 (en)	1990-04-26	1990-04-26	Veterinary composition

Publications (1)

Publication Number	Publication Date
ZA913073B true ZA913073B (en)	1992-03-25

Family

ID=10675074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA913073A ZA913073B (en)	1990-04-26	1991-04-24	Veterinary treatment

Country Status (15)

Country	Link
EP (1)	EP0607122B1 (de)
JP (1)	JPH05506237A (de)
KR (1)	KR100203704B1 (de)
AT (1)	ATE203160T1 (de)
AU (1)	AU648792B2 (de)
CA (1)	CA2081348C (de)
DE (1)	DE69132663T2 (de)
DK (1)	DK0607122T3 (de)
ES (1)	ES2157888T3 (de)
GB (1)	GB9009446D0 (de)
GR (1)	GR3036905T3 (de)
IE (1)	IE911398A1 (de)
NZ (1)	NZ237931A (de)
WO (1)	WO1991016050A1 (de)
ZA (1)	ZA913073B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9007143D0 (en) *	1990-03-30	1990-05-30	Beecham Group Plc	Veterinary composition
US5324840A (en) *	1992-06-11	1994-06-28	Allergan, Inc.	Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1508977A (en) *	1924-01-19	1924-09-16	John Armstrong Hume	Advertising device
NZ177159A (en) *	1974-04-20	1978-03-06	Beecham Group Ltd	Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
US4529720A (en) *	1974-04-20	1985-07-16	Beecham Group, P.L.C.	Antibiotic from Streptomyces clavulicerus
JO984B1 (en) *	1977-10-11	1979-12-01	بيتشام غروب ليمتد	A dry pharmaceutical compound with a suitable dosage unit for oral administration
IL58461A0 (en) *	1978-10-27	1980-01-31	Beecham Group Ltd	Intramammary compositions comprising a clavulanic acid salt
GB9007143D0 (en) *	1990-03-30	1990-05-30	Beecham Group Plc	Veterinary composition

1990
- 1990-04-26 GB GB909009446A patent/GB9009446D0/en active Pending
1991
- 1991-04-22 WO PCT/GB1991/000635 patent/WO1991016050A1/en not_active Ceased
- 1991-04-22 JP JP91508210A patent/JPH05506237A/ja active Pending
- 1991-04-22 DE DE69132663T patent/DE69132663T2/de not_active Revoked
- 1991-04-22 KR KR1019920702637A patent/KR100203704B1/ko not_active Expired - Lifetime
- 1991-04-22 CA CA002081348A patent/CA2081348C/en not_active Expired - Lifetime
- 1991-04-22 DK DK91908740T patent/DK0607122T3/da active
- 1991-04-22 ES ES91908740T patent/ES2157888T3/es not_active Expired - Lifetime
- 1991-04-22 AT AT91908740T patent/ATE203160T1/de not_active IP Right Cessation
- 1991-04-22 EP EP91908740A patent/EP0607122B1/de not_active Revoked
- 1991-04-22 AU AU77581/91A patent/AU648792B2/en not_active Expired
- 1991-04-24 ZA ZA913073A patent/ZA913073B/xx unknown
- 1991-04-24 NZ NZ237931A patent/NZ237931A/en unknown
- 1991-04-25 IE IE139891A patent/IE911398A1/en not_active IP Right Cessation
2001
- 2001-10-16 GR GR20010401775T patent/GR3036905T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2081348C (en)	2001-12-25
EP0607122B1 (de)	2001-07-18
DE69132663D1 (de)	2001-08-23
KR100203704B1 (ko)	1999-06-15
AU7758191A (en)	1991-11-11
DE69132663T2 (de)	2001-10-31
JPH05506237A (ja)	1993-09-16
ES2157888T3 (es)	2001-09-01
GR3036905T3 (en)	2002-01-31
DK0607122T3 (da)	2001-09-24
IE911398A1 (en)	1991-11-06
ATE203160T1 (de)	2001-08-15
NZ237931A (en)	1992-04-28
WO1991016050A1 (en)	1991-10-31
EP0607122A1 (de)	1994-07-27
GB9009446D0 (en)	1990-06-20
AU648792B2 (en)	1994-05-05
CA2081348A1 (en)	1991-10-27
KR930700100A (ko)	1993-03-13

Publication	Publication Date	Title
MY115351A (en)	2003-05-31	Pharmaceutical formulations
AU659444B2 (en)	1995-05-18	Intermediates for the manufacture of 6-fluoro-1, 4-dihydro-4-oxoquinoline carboxylic acids
MY121561A (en)	2006-02-28	Formulation and methods of treatment.
ZA913073B (en)	1992-03-25	Veterinary treatment
ZA912369B (en)	1992-02-26	Veterinary treatment
IL134762A0 (en)	2001-04-30	8α-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
IL82767A (en)	1992-09-06	Synergistic formulation comprising a cephem and a penem derivative for the treatment of bacterial infections
ALY et al.	1995	Bacteriological studies of infectious keratoconjunctivitis in dairy calves.
GB8813670D0 (en)	1988-07-13	Veterinary composition
AU2500788A (en)	1989-05-25	Veterinary treatment
NO890287L (no)	1989-08-04	Fremstilling av beta-laktam-antibiotika.
AU2492892A (en)	1994-03-29	The device for treatment and prophylaxis of mastitis in animals
UA2156A1 (uk)	1994-12-26	Антгельминтний засіб для лікування нематодозів овець
BG100494U (en)	1997-12-30	Antimycotic formulation
BG51699A1 (en)	1993-08-16	Stimulating fertility agent
AU3587289A (en)	1990-12-06	Composition for use in animal husbandry and method of treatment of animals with vitamin